K. Harrington

LBA36 Nivolumab (N) + ipilimumab (I) vs EXTREME as first-line (1L) treatment (tx) for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Final results of CheckMate 651

R. Ferris, A. Argiris, U. Müller-Richter, 2021, Annals of Oncology.

Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarker.

S. Kalloger, C. Gilks, A. Skubitz, 2010, American journal of clinical pathology.

S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.

S. Kalloger, A. Skubitz, S. Pambuccian, 2009, American journal of clinical pathology.

Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration*

C. Clevenger, K. Harrington, 2016, The Journal of Biological Chemistry.

Claudin 4 Is Differentially Expressed between Ovarian Cancer Subtypes and Plays a Role in Spheroid Formation

S. Kalloger, C. Gilks, A. Skubitz, 2011, International journal of molecular sciences.

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

A. Skubitz, R. Jemmerson, R. Vogel, 2010, Journal of ovarian research.